Skip to main content

Advertisement

Log in

Analgesic Effect of Perineural Injection of BoNT/A on Neuropathic Pain Induced by Chronic Constriction Injury of Sciatic Nerve in Rats

  • Original Paper
  • Published:
Neurochemical Research Aims and scope Submit manuscript

Abstract

This study was designed to investigate the analgesic effect of perineural injection of BoNT/A on neuropathic pain induced by sciatic nerve chronic constriction injury (CCI) and possible mechanisms. SD rats were randomly divided into Sham group, CCI group and BoNT/A group. Paw mechanical withdrawal threshold (pMWT) and paw thermal withdrawal latency (pTWL) of each group were detected at different time points after surgery. The expression of myelin markers, autophagy markers and NLRP3 inflammasome-related molecules in injured sciatic nerves were examined at 12 days after surgery. Moreover, C-fiber evoked potential in spinal dorsal horn was recorded. The expression of SNAP-25, neuroinflammation and synaptic plasticity in spinal dorsal horn of each group were examined. Then rats treated with BoNT/A were randomly divided into DMSO group and Wnt agonist group to further explore the regulatory effect of BoNT/A on Wnt pathway. We found that pMWT and pTWL of ipsilateral paw were significantly decreased in CCI group compared with Sham group, which could be improved by perineural injection of BoNT/A at days 7, 9 and 12 after surgery. The peripheral analgesic mechanisms of perineural injection of BoNT/A might be related to the protective effect on myelin sheath by inhibiting NLRP3 inflammasome and promoting autophagy flow, while the central analgesic mechanisms might be associated with inhibition of neuroinflammation and synaptic plasticity in spinal dorsal horn due to inhibiting SNAP-25 and Wnt pathway. As a new route of administration, perineural injection of BoNT/A can relieve CCI induced neuropathic pain probably via both peripheral and central analgesic mechanisms.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10
Fig. 11
Fig. 12
Fig. 13
Fig. 14

Similar content being viewed by others

Data Availability

The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.

Abbreviations

BoNT/A:

Botulinum toxin A

CCI:

Chronic constriction injury

pMWT:

Paw mechanical withdrawal threshold

pTWL:

Paw thermal withdrawal latency

LC3:

Microtubule-associated protein-1 light chain 3

NLRP3:

NOD-like receptor family pyrin domain-containing 3

SNAP-25:

Synaptosomal-associated protein 25 kDa

LTP:

Long-term potentiation

NMDAR:

N-methyl-d-aspartate receptors

SD:

Sprague Dawley

References

  1. Jacobson L, Dengler J, Moore AM (2020) Nerve entrapments. Clin Plast Surg 47:267–278

    Article  PubMed  Google Scholar 

  2. Finnerup NB, Attal N, Haroutounian S, McNicol E, Baron R, Dworkin RH, Gilron I, Haanpaa M, Hansson P, Jensen TS, Kamerman PR, Lund K, Moore A, Raja SN, Rice AS, Rowbotham M, Sena E, Siddall P, Smith BH, Wallace M (2015) Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. Lancet Neurol 14:162–173

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Apalla Z, Sotiriou E, Lallas A, Lazaridou E, Ioannides D (2013) Botulinum toxin A in postherpetic neuralgia: a parallel, randomized, double-blind, single-dose, placebo-controlled trial. Clin J Pain 29:857–864

    Article  PubMed  Google Scholar 

  4. Yuan RY, Sheu JJ, Yu JM, Chen WT, Tseng IJ, Chang HH, Hu CJ (2009) Botulinum toxin for diabetic neuropathic pain: a randomized double-blind crossover trial. Neurology 72:1473–1478

    Article  CAS  PubMed  Google Scholar 

  5. Wu CJ, Lian YJ, Zheng YK, Zhang HF, Chen Y, Xie NC, Wang LJ (2012) Botulinum toxin type A for the treatment of trigeminal neuralgia: results from a randomized, double-blind, placebo-controlled trial. Cephalalgia 32:443–450

    Article  PubMed  Google Scholar 

  6. Fabregat G, De Andres J, Villanueva-Perez VL, Asensio-Samper JM (2013) Subcutaneous and perineural botulinum toxin type a for neuropathic pain: a descriptive review. Clin J Pain 29:1006–1012

    Article  PubMed  Google Scholar 

  7. Matak I, Bolcskei K, Bach-Rojecky L, Helyes Z (2019) Mechanisms of botulinum toxin type A action on pain. Toxins (Basel) 11

  8. Seo M, Lim D, Kim S, Kim T, Kwon BS, Nam K (2021) Effect of botulinum toxin injection and extracorporeal shock wave therapy on nerve regeneration in rats with experimentally induced sciatic nerve injury. Toxins (Basel) 13

  9. Marinelli S, Luvisetto S, Cobianchi S, Makuch W, Obara I, Mezzaroma E, Caruso M, Straface E, Przewlocka B, Pavone F (2010) Botulinum neurotoxin type A counteracts neuropathic pain and facilitates functional recovery after peripheral nerve injury in animal models. Neuroscience 171:316–328

    Article  CAS  PubMed  Google Scholar 

  10. Zychowska M, Rojewska E, Makuch W, Luvisetto S, Pavone F, Marinelli S, Przewlocka B, Mika J (2016) Participation of pro- and anti-nociceptive interleukins in botulinum toxin A-induced analgesia in a rat model of neuropathic pain. Eur J Pharmacol 791:377–388

    Article  CAS  PubMed  Google Scholar 

  11. Buntragulpoontawee M, Chang KV, Vitoonpong T, Pornjaksawan S, Kitisak K, Saokaew S, Kanchanasurakit S (2020) The effectiveness and safety of commonly used injectates for ultrasound-guided hydrodissection treatment of peripheral nerve entrapment syndromes: a systematic review. Front Pharmacol 11:621150

    Article  CAS  PubMed  Google Scholar 

  12. Meyer-Friessem CH, Eitner LB, Kaisler M, Maier C, Vollert J, Westermann A, Zahn PK, Avila Gonzalez CA (2019) Perineural injection of botulinum toxin-A in painful peripheral nerve injury - a case series: pain relief, safety, sensory profile and sample size recommendation. Curr Med Res Opin 35:1793–1803

    Article  CAS  PubMed  Google Scholar 

  13. Xiao PY, Chen JY, Zeng Q, Huang Z, Huang BX, Yu J, Liao SJ (2022) UNC5B overexpression alleviates peripheral neuropathic pain by stimulating netrin-1-dependent autophagic flux in schwann cells. Mol Neurobiol 59:5041–5055

    Article  CAS  PubMed  Google Scholar 

  14. Xu J, Wei X, Gao F, Zhong X, Guo R, Ji Y, Zhou X, Chen J, Yao P, Liu X, Wei X (2020) Nicotinamide adenine dinucleotide phosphate oxidase 2-derived reactive oxygen species contribute to long-term potentiation of C-fiber-evoked field potentials in spinal dorsal horn and persistent mirror-image pain following high-frequency stimulus of the sciatic nerve. Pain 161:758–772

    Article  CAS  PubMed  Google Scholar 

  15. Xiao L, Cheng J, Zhuang Y, Qu W, Muir J, Liang H, Zhang D (2013) Botulinum toxin type A reduces hyperalgesia and TRPV1 expression in rats with neuropathic pain. Pain Med 14:276–286

    Article  PubMed  Google Scholar 

  16. Hughey S, Campbell D, Rapp-Santos K, Cole J, Booth G, Longwell J, Stedje-Larsen E (2022) Refining the rat sciatic nerve block: a novel ultrasound-guided technique. Lab Anim 56:191–195

    Article  CAS  PubMed  Google Scholar 

  17. He JJ, Wei XM, Dou ZL, Zhang JS, Wei ZH, Zhang WX, Jiang L (2021) Ultrasound-guided nerve hydrodissection with 5% dextrose 4 weeks after steroid injection in treatment of carpal tunnel syndrome: a retrospective study. Front Neurol 12:782319

    Article  PubMed  Google Scholar 

  18. Xu T, Li D, Zhou X, Ouyang HD, Zhou LJ, Zhou H, Zhang HM, Wei XH, Liu G, Liu XG (2017) Oral application of magnesium-L-threonate attenuates vincristine-induced allodynia and hyperalgesia by normalization of tumor necrosis factor-alpha/nuclear factor-kappaB signaling. Anesthesiology 126:1151–1168

    Article  CAS  PubMed  Google Scholar 

  19. Huang Z, Xiao PY, Chen JY, Zeng Q, Huang BX, Yu J, Liao SJ (2022) Mammalian sterile 20-like kinase 1 mediates neuropathic pain associated with its effects on regulating mitophagy in Schwann cells. Oxid Med Cell Longev 2022:3458283

    PubMed  PubMed Central  Google Scholar 

  20. Biasizzo M, Kopitar-Jerala N (2020) Interplay between NLRP3 inflammasome and autophagy. Front Immunol 11:591803

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Liu XG (2022) Normalization of neuroinflammation: a new strategy for treatment of persistent pain and memory/emotional deficits in chronic pain. J Inflamm Res 15:5201–5233

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Sheehan GD, Martin MK, Young VA, Powell R, Bhattacharjee A (2021) Thermal hyperalgesia and dynamic weight bearing share similar recovery dynamics in a sciatic nerve entrapment injury model. Neurobiol Pain 10:100079

    Article  PubMed  PubMed Central  Google Scholar 

  23. Lam KHS, Hung CY, Chiang YP, Onishi K, Su DCJ, Clark TB, Reeves KD (2020) Ultrasound-guided nerve hydrodissection for pain management: rationale, methods, current literature, and theoretical mechanisms. J Pain Res 13:1957–1968

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Tumpaj T, Potocnik Tumpaj V, Albano D, Snoj Z (2022) Ultrasound-guided carpal tunnel injections. Radiol Oncol 56:14–22

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Moon YE, Choi JH, Park HJ, Park JH, Kim JH (2016) Ultrasound-guided nerve block with botulinum toxin Type A for intractable neuropathic pain. Toxins (Basel) 8

  26. Kwon SY, Jun EH, Park SJ, Kim Y (2022) Botulinum toxin injection strategy of intractable and relapsed piriformis syndrome: a case report. Medicine (Baltimore) 101:e30950

    Article  CAS  PubMed  Google Scholar 

  27. Cobianchi S, Jaramillo J, Luvisetto S, Pavone F, Navarro X (2017) Botulinum neurotoxin A promotes functional recovery after peripheral nerve injury by increasing regeneration of myelinated fibers. Neuroscience 359:82–91

    Article  CAS  PubMed  Google Scholar 

  28. Gomez-Sanchez JA, Carty L, Iruarrizaga-Lejarreta M, Palomo-Irigoyen M, Varela-Rey M, Griffith M, Hantke J, Macias-Camara N, Azkargorta M, Aurrekoetxea I, De Juan VG, Jefferies HB, Aspichueta P, Elortza F, Aransay AM, Martinez-Chantar ML, Baas F, Mato JM, Mirsky R, Woodhoo A, Jessen KR (2015) Schwann cell autophagy, myelinophagy, initiates myelin clearance from injured nerves. J Cell Biol 210:153–168

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Marinelli S, Nazio F, Tinari A, Ciarlo L, D’Amelio M, Pieroni L, Vacca V, Urbani A, Cecconi F, Malorni W, Pavone F (2014) Schwann cell autophagy counteracts the onset and chronification of neuropathic pain. Pain 155:93–107

    Article  CAS  PubMed  Google Scholar 

  30. Li W, Liang J, Li S, Wang L, Xu S, Jiang S, Song M, Meng H, Zhai D, Tang L, Yang Y, Zhang L, Zhang B (2022) Research progress of targeting NLRP3 inflammasome in peripheral nerve injury and pain. Int Immunopharmacol 110:109026

    Article  CAS  PubMed  Google Scholar 

  31. Cui M, Liang J, Xu D, Zhao L, Zhang X, Zhang L, Ren S, Liu D, Niu X, Zang YJ, Zhang B (2020) NLRP3 inflammasome is involved in nerve recovery after sciatic nerve injury. Int Immunopharmacol 84:106492

    Article  CAS  PubMed  Google Scholar 

  32. Luvisetto S (2021) Botulinum neurotoxins in central nervous system: an overview from animal models to human therapy. Toxins (Basel) 13

  33. Liu S, Liu YP, Huang ZJ, Zhang YK, Song AA, Ma PC, Song XJ (2015) Wnt/Ryk signaling contributes to neuropathic pain by regulating sensory neuron excitability and spinal synaptic plasticity in rats. Pain 156:2572–2584

    Article  CAS  PubMed  Google Scholar 

  34. Mika J, Rojewska E, Makuch W, Korostynski M, Luvisetto S, Marinelli S, Pavone F, Przewlocka B (2011) The effect of botulinum neurotoxin A on sciatic nerve injury-induced neuroimmunological changes in rat dorsal root ganglia and spinal cord. Neuroscience 175:358–366

    Article  CAS  PubMed  Google Scholar 

  35. Zhang YK, Huang ZJ, Liu S, Liu YP, Song AA, Song XJ (2013) WNT signaling underlies the pathogenesis of neuropathic pain in rodents. J Clin Invest 123:2268–2286

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

We are very grateful to our corporate sponsor Lanzhou Biotechnique Development Co., LTD.

Funding

This study was supported by grants from the Natural Science Foundation of Guangdong Province (2021A1515010313), the Guangdong Provincial Key Laboratory of Diagnosis and Treatment of Major Neurological Diseases (2020B1212060017), Guangdong Provincial Clinical Research Center for Neurological Diseases (2020B1111170002), Southern China International Joint Research Center for Early Intervention and Functional Rehabilitation of Neurological Diseases (2015B050501003 and 2020A0505020004), Guangdong Provincial Engineering Center for Major Neurological Disease Treatment, Guangdong Provincial Translational Medicine Innovation Platform for Diagnosis and Treatment of Major Neurological Disease, Guangzhou Clinical Research and Translational Center for Major Neurological Diseases (201604020010), Guangzhou Science and Technology Program (20220610195), a crosswise project of First Affiliated Hospital, Sun Yat-sen University (2020027).

Author information

Authors and Affiliations

Authors

Contributions

All authors contributed to the study conception and design. Conceived and designed the experiments: WZ and LJ. Material preparation, data collection and analysis: JH, MW and ZS. Wrote the paper: JH and XW. All authors read and approved the final manuscript.

Corresponding authors

Correspondence to Li Jiang or Wei-xi Zhang.

Ethics declarations

Conflict of interest

The authors confirm that there is no conflict of interest.

Ethical Approval

This study was approved by Institutional Animal Care and Use Committee, Sun Yat-Sen University (Approval NO. SYSU-IACUC-2022-000798).

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

He, Jj., Wei, Xm., Wu, Ml. et al. Analgesic Effect of Perineural Injection of BoNT/A on Neuropathic Pain Induced by Chronic Constriction Injury of Sciatic Nerve in Rats. Neurochem Res 48, 2161–2174 (2023). https://doi.org/10.1007/s11064-023-03893-0

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11064-023-03893-0

Keywords

Navigation